A proposed ban on formaldehyde in chemical hair straightening products -- linked to cancer and other health risks -- h ...
The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from ...
The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...
A proposed Mississippi bill would let bounty hunters track undocumented migrants. The DeSoto County DA announced it this week. Here's what we know.
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
The U.S. Food and Drug Administration has issued a recall on a popular skin moisturizer that's available nationwide. Do you have this product?
Robert F. Kennedy Jr., Trump’s pick to be health secretary, is keeping his financial stake in major vaccine litigation ...
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback